US FDA approves over-the-counter sale of overdose reversal drug Narcan

Posted on AllSides March 29th, 2023
From The Center
REUTERS/Adrees Latif

The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Inc's (EBS.N) Narcan, allowing for easier availability of the life-saving medication used to reverse opioid overdoses.

The formal decision makes Narcan the first naloxone-based drug available without a prescription.

Emergent said it will make Narcan available on U.S. store shelves and online retailers by late summer.

"I think it's a big win. The question now remains about the cost," said Noa Krawczyk, assistant professor at the NYU Grossman School of Medicine.

The contract drugmaker declined...

Read full story


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for Reuters
Learn about media bias

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right